Covid Vaccine Windfall Turns for Pfizer and Moderna| Trending Viral hub

The United States suffered a Covid panic attack during Thanksgiving week two years ago. The Omicron variant had emerged as a creature from the Black Lagoon. Public health officials indicated we would need another updated booster. Stock prices in Pfizer and Modern arose.

By the end of the month, Pfizer’s stock market value had exceeded $300 billion, 50% more than at the beginning of the pandemic. Moderna shares had soared more than 1,000% during the same period. In 2022, Pfizer became the first pharmaceutical company to record more than $100 billion in annual sales due to government purchases of its vaccines and antiviral pills.